Screening in Myocardial Perfusion Patients

NCT00943241 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 322

Last updated 2013-02-13

No results posted yet for this study

Summary

To expand the understanding of the uptake and distribution of Tc-99m sestamibi in the breast in a normal female population undergoing myocardial perfusion imaging using Molecular Breast Imaging (MBI).

Conditions

Sponsors & Collaborators

  • Gamma Medica-Ideas

    collaborator INDUSTRY
  • Mayo Clinic

    lead OTHER

Principal Investigators

  • Deborah J. Rhodes, M.D. · Mayo Clinic

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-07-31
Primary Completion
2010-06-30
Completion
2010-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00943241 on ClinicalTrials.gov